nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Disulfiram—alcohol dependence	0.186	0.501	CbGbCtD
Bexarotene—CYP3A4—Disulfiram—alcohol dependence	0.108	0.291	CbGbCtD
Bexarotene—CYP3A4—Citalopram—alcohol dependence	0.0772	0.208	CbGbCtD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.00875	0.0578	CbGpPWpGaD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.00822	0.0543	CbGpPWpGaD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.00744	0.0491	CbGpPWpGaD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.00699	0.0462	CbGpPWpGaD
Bexarotene—RXRA—forebrain—alcohol dependence	0.00573	0.081	CbGeAlD
Bexarotene—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00439	0.029	CbGpPWpGaD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—ADH1A—alcohol dependence	0.00429	0.0283	CbGpPWpGaD
Bexarotene—RXRG—cardiovascular system—alcohol dependence	0.00425	0.0601	CbGeAlD
Bexarotene—RXRB—pancreas—alcohol dependence	0.00389	0.0549	CbGeAlD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—ADH4—alcohol dependence	0.00364	0.0241	CbGpPWpGaD
Bexarotene—RXRA—endocrine gland—alcohol dependence	0.00332	0.047	CbGeAlD
Bexarotene—RXRG—midbrain—alcohol dependence	0.00332	0.047	CbGeAlD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00321	0.0212	CbGpPWpGaD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—CYP2E1—alcohol dependence	0.00312	0.0206	CbGpPWpGaD
Bexarotene—RXRA—nervous system—alcohol dependence	0.00311	0.044	CbGeAlD
Bexarotene—RXRA—liver—alcohol dependence	0.003	0.0424	CbGeAlD
Bexarotene—RXRA—central nervous system—alcohol dependence	0.00299	0.0423	CbGeAlD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—CYP2E1—alcohol dependence	0.00294	0.0194	CbGpPWpGaD
Bexarotene—RXRG—endocrine gland—alcohol dependence	0.00292	0.0412	CbGeAlD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00281	0.0186	CbGpPWpGaD
Bexarotene—RXRG—testis—alcohol dependence	0.00278	0.0393	CbGeAlD
Bexarotene—RXRB—endocrine gland—alcohol dependence	0.00274	0.0388	CbGeAlD
Bexarotene—RXRG—nervous system—alcohol dependence	0.00273	0.0386	CbGeAlD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00266	0.0176	CbGpPWpGaD
Bexarotene—RXRG—central nervous system—alcohol dependence	0.00263	0.0372	CbGeAlD
Bexarotene—RXRB—testis—alcohol dependence	0.00262	0.037	CbGeAlD
Bexarotene—RXRB—nervous system—alcohol dependence	0.00257	0.0363	CbGeAlD
Bexarotene—RXRB—liver—alcohol dependence	0.00247	0.035	CbGeAlD
Bexarotene—RXRB—central nervous system—alcohol dependence	0.00247	0.0349	CbGeAlD
Bexarotene—RXRB—cerebellum—alcohol dependence	0.00242	0.0342	CbGeAlD
Bexarotene—RXRA—brain—alcohol dependence	0.00238	0.0336	CbGeAlD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00233	0.0154	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00226	0.015	CbGpPWpGaD
Bexarotene—RXRG—brain—alcohol dependence	0.00209	0.0295	CbGeAlD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00198	0.0131	CbGpPWpGaD
Bexarotene—RXRB—brain—alcohol dependence	0.00196	0.0277	CbGeAlD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00192	0.0127	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—ALDH3A1—alcohol dependence	0.00181	0.0119	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—ADH6—alcohol dependence	0.00171	0.0113	CbGpPWpGaD
Bexarotene—CYP2C9—CYP2E1 reactions—CYP2E1—alcohol dependence	0.0017	0.0112	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00169	0.0111	CbGpPWpGaD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00168	0.0111	CbGpPWpGaD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—CYP2E1—alcohol dependence	0.00153	0.0101	CbGpPWpGaD
Bexarotene—RXRA—Orphan transporters—GABRB1—alcohol dependence	0.00153	0.0101	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—EP300—alcohol dependence	0.00148	0.00978	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00148	0.00978	CbGpPWpGaD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00148	0.00975	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—ADH1A—alcohol dependence	0.00141	0.00934	CbGpPWpGaD
Bexarotene—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00141	0.00929	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0014	0.00924	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—EP300—alcohol dependence	0.00139	0.00919	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—alcohol dependence	0.00139	0.00919	CbGpPWpGaD
Bexarotene—RXRA—Endogenous sterols—POMC—alcohol dependence	0.00135	0.00893	CbGpPWpGaD
Bexarotene—RXRA—Orphan transporters—GABRA2—alcohol dependence	0.0013	0.00859	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—ADH4—alcohol dependence	0.0012	0.00794	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.0012	0.00792	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00119	0.00785	CbGpPWpGaD
Bexarotene—CYP2C9—cardiovascular system—alcohol dependence	0.00117	0.0166	CbGeAlD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00117	0.00774	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—ADH7—alcohol dependence	0.00117	0.0077	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—GGT2—alcohol dependence	0.00112	0.00738	CbGpPWpGaD
Bexarotene—CYP2C9—Xenobiotics—CYP2E1—alcohol dependence	0.00105	0.00696	CbGpPWpGaD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00104	0.00687	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—ADH7—alcohol dependence	0.00102	0.00675	CbGpPWpGaD
Bexarotene—CYP2C9—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00101	0.0067	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—AVP—alcohol dependence	0.00101	0.00669	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000993	0.00656	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—GGT2—alcohol dependence	0.00098	0.00647	CbGpPWpGaD
Bexarotene—CYP2C9—digestive system—alcohol dependence	0.000975	0.0138	CbGeAlD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00095	0.00628	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000939	0.0062	CbGpPWpGaD
Bexarotene—CYP2C9—blood—alcohol dependence	0.000929	0.0131	CbGeAlD
Bexarotene—RXRA—Biological oxidations—ADH1B—alcohol dependence	0.000896	0.00592	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000883	0.00583	CbGpPWpGaD
Bexarotene—RXRA—REV-ERBA represses gene expression—EP300—alcohol dependence	0.000867	0.00573	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000845	0.00558	CbGpPWpGaD
Bexarotene—RXRA—RORA activates circadian gene expression—EP300—alcohol dependence	0.000839	0.00554	CbGpPWpGaD
Bexarotene—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000831	0.00549	CbGpPWpGaD
Bexarotene—CYP2C9—endocrine gland—alcohol dependence	0.000806	0.0114	CbGeAlD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000791	0.00522	CbGpPWpGaD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000782	0.00517	CbGpPWpGaD
Bexarotene—CYP3A4—digestive system—alcohol dependence	0.000743	0.0105	CbGeAlD
Bexarotene—RXRA—Biological oxidations—MAOB—alcohol dependence	0.000743	0.00491	CbGpPWpGaD
Bexarotene—CYP2C9—liver—alcohol dependence	0.000726	0.0103	CbGeAlD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—EP300—alcohol dependence	0.000725	0.00479	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000718	0.00475	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CCAR1—alcohol dependence	0.000712	0.0047	CbGpPWpGaD
Bexarotene—CYP3A4—blood—alcohol dependence	0.000708	0.01	CbGeAlD
Bexarotene—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000695	0.00459	CbGpPWpGaD
Bexarotene—Libido decreased—Citalopram—alcohol dependence	0.000694	0.00171	CcSEcCtD
Bexarotene—Tinnitus—Acamprosate—alcohol dependence	0.000693	0.00171	CcSEcCtD
Bexarotene—Connective tissue disorder—Naltrexone—alcohol dependence	0.000691	0.0017	CcSEcCtD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000689	0.00455	CbGpPWpGaD
Bexarotene—Increased appetite—Citalopram—alcohol dependence	0.000685	0.00169	CcSEcCtD
Bexarotene—Thirst—Citalopram—alcohol dependence	0.000676	0.00167	CcSEcCtD
Bexarotene—Rash—Disulfiram—alcohol dependence	0.000676	0.00166	CcSEcCtD
Bexarotene—Dermatitis bullous—Citalopram—alcohol dependence	0.000674	0.00166	CcSEcCtD
Bexarotene—Headache—Disulfiram—alcohol dependence	0.000671	0.00165	CcSEcCtD
Bexarotene—RXRB—Gene Expression—CCAR1—alcohol dependence	0.000669	0.00442	CbGpPWpGaD
Bexarotene—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000668	0.00442	CbGpPWpGaD
Bexarotene—Purpura—Citalopram—alcohol dependence	0.000668	0.00164	CcSEcCtD
Bexarotene—Chills—Acamprosate—alcohol dependence	0.000667	0.00164	CcSEcCtD
Bexarotene—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000665	0.00439	CbGpPWpGaD
Bexarotene—Arthritis—Citalopram—alcohol dependence	0.000662	0.00163	CcSEcCtD
Bexarotene—Lethargy—Citalopram—alcohol dependence	0.000657	0.00162	CcSEcCtD
Bexarotene—Cerebrovascular accident—Citalopram—alcohol dependence	0.000657	0.00162	CcSEcCtD
Bexarotene—Eye disorder—Naltrexone—alcohol dependence	0.000657	0.00162	CcSEcCtD
Bexarotene—Alopecia—Acamprosate—alcohol dependence	0.000656	0.00162	CcSEcCtD
Bexarotene—Tinnitus—Naltrexone—alcohol dependence	0.000655	0.00161	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000655	0.00433	CbGpPWpGaD
Bexarotene—Cardiac disorder—Naltrexone—alcohol dependence	0.000652	0.00161	CcSEcCtD
Bexarotene—Malnutrition—Acamprosate—alcohol dependence	0.000647	0.00159	CcSEcCtD
Bexarotene—Hyponatraemia—Citalopram—alcohol dependence	0.000646	0.00159	CcSEcCtD
Bexarotene—Osteoarthritis—Citalopram—alcohol dependence	0.000644	0.00159	CcSEcCtD
Bexarotene—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.000639	0.00157	CcSEcCtD
Bexarotene—Angiopathy—Naltrexone—alcohol dependence	0.000638	0.00157	CcSEcCtD
Bexarotene—Flatulence—Acamprosate—alcohol dependence	0.000637	0.00157	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—ADH6—alcohol dependence	0.000637	0.00421	CbGpPWpGaD
Bexarotene—Tension—Acamprosate—alcohol dependence	0.000635	0.00156	CcSEcCtD
Bexarotene—Affect lability—Citalopram—alcohol dependence	0.000634	0.00156	CcSEcCtD
Bexarotene—Migraine—Citalopram—alcohol dependence	0.000634	0.00156	CcSEcCtD
Bexarotene—Dysgeusia—Acamprosate—alcohol dependence	0.000633	0.00156	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—ALDH2—alcohol dependence	0.000631	0.00417	CbGpPWpGaD
Bexarotene—Chills—Naltrexone—alcohol dependence	0.000631	0.00155	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00063	0.00416	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—SLC6A4—alcohol dependence	0.000629	0.00416	CbGpPWpGaD
Bexarotene—Nervousness—Acamprosate—alcohol dependence	0.000628	0.00155	CcSEcCtD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000628	0.00415	CbGpPWpGaD
Bexarotene—Back pain—Acamprosate—alcohol dependence	0.000625	0.00154	CcSEcCtD
Bexarotene—Muscle spasms—Acamprosate—alcohol dependence	0.000622	0.00153	CcSEcCtD
Bexarotene—Face oedema—Citalopram—alcohol dependence	0.000621	0.00153	CcSEcCtD
Bexarotene—Alopecia—Naltrexone—alcohol dependence	0.000621	0.00153	CcSEcCtD
Bexarotene—CYP3A4—endocrine gland—alcohol dependence	0.000614	0.00868	CbGeAlD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—alcohol dependence	0.000613	0.00405	CbGpPWpGaD
Bexarotene—Urinary retention—Citalopram—alcohol dependence	0.000612	0.00151	CcSEcCtD
Bexarotene—Malnutrition—Naltrexone—alcohol dependence	0.000612	0.00151	CcSEcCtD
Bexarotene—Mood swings—Citalopram—alcohol dependence	0.00061	0.0015	CcSEcCtD
Bexarotene—Ataxia—Citalopram—alcohol dependence	0.000605	0.00149	CcSEcCtD
Bexarotene—Flatulence—Naltrexone—alcohol dependence	0.000603	0.00148	CcSEcCtD
Bexarotene—Tension—Naltrexone—alcohol dependence	0.0006	0.00148	CcSEcCtD
Bexarotene—Ill-defined disorder—Acamprosate—alcohol dependence	0.0006	0.00148	CcSEcCtD
Bexarotene—Dysgeusia—Naltrexone—alcohol dependence	0.000599	0.00148	CcSEcCtD
Bexarotene—Dehydration—Citalopram—alcohol dependence	0.000599	0.00147	CcSEcCtD
Bexarotene—Anaemia—Acamprosate—alcohol dependence	0.000598	0.00147	CcSEcCtD
Bexarotene—Liver function test abnormal—Citalopram—alcohol dependence	0.000594	0.00146	CcSEcCtD
Bexarotene—Agitation—Acamprosate—alcohol dependence	0.000594	0.00146	CcSEcCtD
Bexarotene—Nervousness—Naltrexone—alcohol dependence	0.000594	0.00146	CcSEcCtD
Bexarotene—Back pain—Naltrexone—alcohol dependence	0.000592	0.00146	CcSEcCtD
Bexarotene—Dry skin—Citalopram—alcohol dependence	0.00059	0.00145	CcSEcCtD
Bexarotene—Muscle spasms—Naltrexone—alcohol dependence	0.000588	0.00145	CcSEcCtD
Bexarotene—Hypokalaemia—Citalopram—alcohol dependence	0.000586	0.00144	CcSEcCtD
Bexarotene—Malaise—Acamprosate—alcohol dependence	0.000583	0.00144	CcSEcCtD
Bexarotene—Vertigo—Acamprosate—alcohol dependence	0.000581	0.00143	CcSEcCtD
Bexarotene—Syncope—Acamprosate—alcohol dependence	0.00058	0.00143	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00058	0.00143	CcSEcCtD
Bexarotene—Leukopenia—Acamprosate—alcohol dependence	0.000579	0.00143	CcSEcCtD
Bexarotene—CYP3A4—nervous system—alcohol dependence	0.000575	0.00813	CbGeAlD
Bexarotene—Palpitations—Acamprosate—alcohol dependence	0.000571	0.00141	CcSEcCtD
Bexarotene—Loss of consciousness—Acamprosate—alcohol dependence	0.000568	0.0014	CcSEcCtD
Bexarotene—Muscular weakness—Citalopram—alcohol dependence	0.000568	0.0014	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.000568	0.0014	CcSEcCtD
Bexarotene—Ill-defined disorder—Naltrexone—alcohol dependence	0.000568	0.0014	CcSEcCtD
Bexarotene—Cough—Acamprosate—alcohol dependence	0.000564	0.00139	CcSEcCtD
Bexarotene—Agitation—Naltrexone—alcohol dependence	0.000562	0.00138	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—SLC6A3—alcohol dependence	0.000561	0.00371	CbGpPWpGaD
Bexarotene—Abdominal distension—Citalopram—alcohol dependence	0.00056	0.00138	CcSEcCtD
Bexarotene—Hypertension—Acamprosate—alcohol dependence	0.000558	0.00137	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000557	0.00368	CbGpPWpGaD
Bexarotene—Influenza—Citalopram—alcohol dependence	0.000556	0.00137	CcSEcCtD
Bexarotene—Dysphagia—Citalopram—alcohol dependence	0.000556	0.00137	CcSEcCtD
Bexarotene—CYP3A4—liver—alcohol dependence	0.000554	0.00783	CbGeAlD
Bexarotene—CYP3A4—central nervous system—alcohol dependence	0.000554	0.00783	CbGeAlD
Bexarotene—Malaise—Naltrexone—alcohol dependence	0.000552	0.00136	CcSEcCtD
Bexarotene—Eosinophilia—Citalopram—alcohol dependence	0.000551	0.00136	CcSEcCtD
Bexarotene—Chest pain—Acamprosate—alcohol dependence	0.000551	0.00136	CcSEcCtD
Bexarotene—Myalgia—Acamprosate—alcohol dependence	0.000551	0.00136	CcSEcCtD
Bexarotene—Arthralgia—Acamprosate—alcohol dependence	0.000551	0.00136	CcSEcCtD
Bexarotene—Syncope—Naltrexone—alcohol dependence	0.000549	0.00135	CcSEcCtD
Bexarotene—Anxiety—Acamprosate—alcohol dependence	0.000549	0.00135	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000547	0.00135	CcSEcCtD
Bexarotene—Pancreatitis—Citalopram—alcohol dependence	0.000545	0.00134	CcSEcCtD
Bexarotene—Discomfort—Acamprosate—alcohol dependence	0.000544	0.00134	CcSEcCtD
Bexarotene—Angina pectoris—Citalopram—alcohol dependence	0.000542	0.00133	CcSEcCtD
Bexarotene—Palpitations—Naltrexone—alcohol dependence	0.000541	0.00133	CcSEcCtD
Bexarotene—Dry mouth—Acamprosate—alcohol dependence	0.000538	0.00133	CcSEcCtD
Bexarotene—Loss of consciousness—Naltrexone—alcohol dependence	0.000538	0.00132	CcSEcCtD
Bexarotene—Bronchitis—Citalopram—alcohol dependence	0.000535	0.00132	CcSEcCtD
Bexarotene—Cough—Naltrexone—alcohol dependence	0.000534	0.00131	CcSEcCtD
Bexarotene—Confusional state—Acamprosate—alcohol dependence	0.000532	0.00131	CcSEcCtD
Bexarotene—Pancytopenia—Citalopram—alcohol dependence	0.000528	0.0013	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—GGT1—alcohol dependence	0.000528	0.00349	CbGpPWpGaD
Bexarotene—Hypertension—Naltrexone—alcohol dependence	0.000528	0.0013	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—ADH1A—alcohol dependence	0.000528	0.00349	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000525	0.00347	CbGpPWpGaD
Bexarotene—Infection—Acamprosate—alcohol dependence	0.000524	0.00129	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000522	0.00345	CbGpPWpGaD
Bexarotene—Myalgia—Naltrexone—alcohol dependence	0.000521	0.00128	CcSEcCtD
Bexarotene—Arthralgia—Naltrexone—alcohol dependence	0.000521	0.00128	CcSEcCtD
Bexarotene—Chest pain—Naltrexone—alcohol dependence	0.000521	0.00128	CcSEcCtD
Bexarotene—Dysuria—Citalopram—alcohol dependence	0.00052	0.00128	CcSEcCtD
Bexarotene—Shock—Acamprosate—alcohol dependence	0.000519	0.00128	CcSEcCtD
Bexarotene—Anxiety—Naltrexone—alcohol dependence	0.000519	0.00128	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000517	0.00127	CcSEcCtD
Bexarotene—Thrombocytopenia—Acamprosate—alcohol dependence	0.000517	0.00127	CcSEcCtD
Bexarotene—Tachycardia—Acamprosate—alcohol dependence	0.000515	0.00127	CcSEcCtD
Bexarotene—Discomfort—Naltrexone—alcohol dependence	0.000515	0.00127	CcSEcCtD
Bexarotene—Pollakiuria—Citalopram—alcohol dependence	0.000514	0.00127	CcSEcCtD
Bexarotene—Skin disorder—Acamprosate—alcohol dependence	0.000513	0.00126	CcSEcCtD
Bexarotene—Erectile dysfunction—Citalopram—alcohol dependence	0.000512	0.00126	CcSEcCtD
Bexarotene—Hyperhidrosis—Acamprosate—alcohol dependence	0.00051	0.00126	CcSEcCtD
Bexarotene—Dry mouth—Naltrexone—alcohol dependence	0.000509	0.00125	CcSEcCtD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000509	0.00336	CbGpPWpGaD
Bexarotene—Photosensitivity reaction—Citalopram—alcohol dependence	0.000508	0.00125	CcSEcCtD
Bexarotene—Weight increased—Citalopram—alcohol dependence	0.000506	0.00125	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—CYP2E1—alcohol dependence	0.000505	0.00334	CbGpPWpGaD
Bexarotene—Confusional state—Naltrexone—alcohol dependence	0.000503	0.00124	CcSEcCtD
Bexarotene—Weight decreased—Citalopram—alcohol dependence	0.000503	0.00124	CcSEcCtD
Bexarotene—Anorexia—Acamprosate—alcohol dependence	0.000503	0.00124	CcSEcCtD
Bexarotene—Hyperglycaemia—Citalopram—alcohol dependence	0.000502	0.00124	CcSEcCtD
Bexarotene—Oedema—Naltrexone—alcohol dependence	0.000499	0.00123	CcSEcCtD
Bexarotene—Pneumonia—Citalopram—alcohol dependence	0.000499	0.00123	CcSEcCtD
Bexarotene—Infection—Naltrexone—alcohol dependence	0.000496	0.00122	CcSEcCtD
Bexarotene—Shock—Naltrexone—alcohol dependence	0.000491	0.00121	CcSEcCtD
Bexarotene—Nervous system disorder—Naltrexone—alcohol dependence	0.00049	0.00121	CcSEcCtD
Bexarotene—Tachycardia—Naltrexone—alcohol dependence	0.000487	0.0012	CcSEcCtD
Bexarotene—Neuropathy peripheral—Citalopram—alcohol dependence	0.000486	0.0012	CcSEcCtD
Bexarotene—Skin disorder—Naltrexone—alcohol dependence	0.000485	0.00119	CcSEcCtD
Bexarotene—Stomatitis—Citalopram—alcohol dependence	0.000484	0.00119	CcSEcCtD
Bexarotene—Jaundice—Citalopram—alcohol dependence	0.000484	0.00119	CcSEcCtD
Bexarotene—Hyperhidrosis—Naltrexone—alcohol dependence	0.000483	0.00119	CcSEcCtD
Bexarotene—Urinary tract infection—Citalopram—alcohol dependence	0.000482	0.00119	CcSEcCtD
Bexarotene—Conjunctivitis—Citalopram—alcohol dependence	0.000482	0.00119	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000481	0.00118	CcSEcCtD
Bexarotene—Insomnia—Acamprosate—alcohol dependence	0.000477	0.00118	CcSEcCtD
Bexarotene—Anorexia—Naltrexone—alcohol dependence	0.000476	0.00117	CcSEcCtD
Bexarotene—Sweating—Citalopram—alcohol dependence	0.000476	0.00117	CcSEcCtD
Bexarotene—Paraesthesia—Acamprosate—alcohol dependence	0.000474	0.00117	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000474	0.00313	CbGpPWpGaD
Bexarotene—Haematuria—Citalopram—alcohol dependence	0.000473	0.00116	CcSEcCtD
Bexarotene—Dyspnoea—Acamprosate—alcohol dependence	0.000471	0.00116	CcSEcCtD
Bexarotene—Somnolence—Acamprosate—alcohol dependence	0.000469	0.00116	CcSEcCtD
Bexarotene—Epistaxis—Citalopram—alcohol dependence	0.000468	0.00115	CcSEcCtD
Bexarotene—Sinusitis—Citalopram—alcohol dependence	0.000465	0.00115	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—GGT1—alcohol dependence	0.000465	0.00307	CbGpPWpGaD
Bexarotene—Dyspepsia—Acamprosate—alcohol dependence	0.000465	0.00114	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—GGT1—alcohol dependence	0.000463	0.00306	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.00046	0.00304	CbGpPWpGaD
Bexarotene—Decreased appetite—Acamprosate—alcohol dependence	0.000459	0.00113	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000456	0.00112	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000455	0.00112	CcSEcCtD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000455	0.003	CbGpPWpGaD
Bexarotene—Insomnia—Naltrexone—alcohol dependence	0.000452	0.00111	CcSEcCtD
Bexarotene—Constipation—Acamprosate—alcohol dependence	0.000451	0.00111	CcSEcCtD
Bexarotene—Pain—Acamprosate—alcohol dependence	0.000451	0.00111	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—ADH4—alcohol dependence	0.000449	0.00296	CbGpPWpGaD
Bexarotene—Paraesthesia—Naltrexone—alcohol dependence	0.000448	0.0011	CcSEcCtD
Bexarotene—Haemoglobin—Citalopram—alcohol dependence	0.000448	0.0011	CcSEcCtD
Bexarotene—RXRA—Circadian Clock—EP300—alcohol dependence	0.000447	0.00295	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000446	0.00295	CbGpPWpGaD
Bexarotene—Rhinitis—Citalopram—alcohol dependence	0.000446	0.0011	CcSEcCtD
Bexarotene—Haemorrhage—Citalopram—alcohol dependence	0.000445	0.0011	CcSEcCtD
Bexarotene—Dyspnoea—Naltrexone—alcohol dependence	0.000445	0.0011	CcSEcCtD
Bexarotene—Somnolence—Naltrexone—alcohol dependence	0.000444	0.00109	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000444	0.00293	CbGpPWpGaD
Bexarotene—Hypoaesthesia—Citalopram—alcohol dependence	0.000443	0.00109	CcSEcCtD
Bexarotene—Pharyngitis—Citalopram—alcohol dependence	0.000442	0.00109	CcSEcCtD
Bexarotene—Urinary tract disorder—Citalopram—alcohol dependence	0.00044	0.00108	CcSEcCtD
Bexarotene—Oedema peripheral—Citalopram—alcohol dependence	0.000439	0.00108	CcSEcCtD
Bexarotene—Connective tissue disorder—Citalopram—alcohol dependence	0.000438	0.00108	CcSEcCtD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000438	0.00289	CbGpPWpGaD
Bexarotene—Urethral disorder—Citalopram—alcohol dependence	0.000437	0.00108	CcSEcCtD
Bexarotene—Feeling abnormal—Acamprosate—alcohol dependence	0.000435	0.00107	CcSEcCtD
Bexarotene—Decreased appetite—Naltrexone—alcohol dependence	0.000434	0.00107	CcSEcCtD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000432	0.00285	CbGpPWpGaD
Bexarotene—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000432	0.00106	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000431	0.00106	CcSEcCtD
Bexarotene—Fatigue—Naltrexone—alcohol dependence	0.00043	0.00106	CcSEcCtD
Bexarotene—Pain—Naltrexone—alcohol dependence	0.000427	0.00105	CcSEcCtD
Bexarotene—Constipation—Naltrexone—alcohol dependence	0.000427	0.00105	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.00042	0.00278	CbGpPWpGaD
Bexarotene—Abdominal pain—Acamprosate—alcohol dependence	0.000417	0.00103	CcSEcCtD
Bexarotene—Body temperature increased—Acamprosate—alcohol dependence	0.000417	0.00103	CcSEcCtD
Bexarotene—Eye disorder—Citalopram—alcohol dependence	0.000416	0.00102	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000415	0.00274	CbGpPWpGaD
Bexarotene—RXRA—Biological oxidations—MAOA—alcohol dependence	0.000415	0.00274	CbGpPWpGaD
Bexarotene—Tinnitus—Citalopram—alcohol dependence	0.000415	0.00102	CcSEcCtD
Bexarotene—Cardiac disorder—Citalopram—alcohol dependence	0.000413	0.00102	CcSEcCtD
Bexarotene—Feeling abnormal—Naltrexone—alcohol dependence	0.000411	0.00101	CcSEcCtD
Bexarotene—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000408	0.00101	CcSEcCtD
Bexarotene—Angiopathy—Citalopram—alcohol dependence	0.000404	0.000995	CcSEcCtD
Bexarotene—Chills—Citalopram—alcohol dependence	0.0004	0.000984	CcSEcCtD
Bexarotene—Arrhythmia—Citalopram—alcohol dependence	0.000398	0.00098	CcSEcCtD
Bexarotene—Abdominal pain—Naltrexone—alcohol dependence	0.000395	0.000972	CcSEcCtD
Bexarotene—Body temperature increased—Naltrexone—alcohol dependence	0.000395	0.000972	CcSEcCtD
Bexarotene—Alopecia—Citalopram—alcohol dependence	0.000394	0.000969	CcSEcCtD
Bexarotene—Hypersensitivity—Acamprosate—alcohol dependence	0.000389	0.000958	CcSEcCtD
Bexarotene—Erythema—Citalopram—alcohol dependence	0.000388	0.000955	CcSEcCtD
Bexarotene—Malnutrition—Citalopram—alcohol dependence	0.000388	0.000955	CcSEcCtD
Bexarotene—Flatulence—Citalopram—alcohol dependence	0.000382	0.000941	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—ADH7—alcohol dependence	0.000382	0.00252	CbGpPWpGaD
Bexarotene—Tension—Citalopram—alcohol dependence	0.00038	0.000937	CcSEcCtD
Bexarotene—Dysgeusia—Citalopram—alcohol dependence	0.00038	0.000935	CcSEcCtD
Bexarotene—Asthenia—Acamprosate—alcohol dependence	0.000379	0.000933	CcSEcCtD
Bexarotene—Nervousness—Citalopram—alcohol dependence	0.000377	0.000927	CcSEcCtD
Bexarotene—Back pain—Citalopram—alcohol dependence	0.000375	0.000923	CcSEcCtD
Bexarotene—Pruritus—Acamprosate—alcohol dependence	0.000373	0.00092	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.000373	0.00247	CbGpPWpGaD
Bexarotene—Muscle spasms—Citalopram—alcohol dependence	0.000373	0.000918	CcSEcCtD
Bexarotene—Hypersensitivity—Naltrexone—alcohol dependence	0.000368	0.000906	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—GGT2—alcohol dependence	0.000366	0.00242	CbGpPWpGaD
Bexarotene—Diarrhoea—Acamprosate—alcohol dependence	0.000361	0.000889	CcSEcCtD
Bexarotene—Ill-defined disorder—Citalopram—alcohol dependence	0.00036	0.000886	CcSEcCtD
Bexarotene—Anaemia—Citalopram—alcohol dependence	0.000358	0.000882	CcSEcCtD
Bexarotene—Asthenia—Naltrexone—alcohol dependence	0.000358	0.000882	CcSEcCtD
Bexarotene—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000357	0.00236	CbGpPWpGaD
Bexarotene—Agitation—Citalopram—alcohol dependence	0.000356	0.000877	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000355	0.00234	CbGpPWpGaD
Bexarotene—Pruritus—Naltrexone—alcohol dependence	0.000353	0.00087	CcSEcCtD
Bexarotene—Malaise—Citalopram—alcohol dependence	0.00035	0.000861	CcSEcCtD
Bexarotene—Dizziness—Acamprosate—alcohol dependence	0.000349	0.000859	CcSEcCtD
Bexarotene—RXRA—Gene Expression—CCAR1—alcohol dependence	0.000349	0.0023	CbGpPWpGaD
Bexarotene—Vertigo—Citalopram—alcohol dependence	0.000348	0.000858	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000348	0.0023	CbGpPWpGaD
Bexarotene—Syncope—Citalopram—alcohol dependence	0.000348	0.000856	CcSEcCtD
Bexarotene—Leukopenia—Citalopram—alcohol dependence	0.000347	0.000855	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000344	0.00227	CbGpPWpGaD
Bexarotene—Palpitations—Citalopram—alcohol dependence	0.000343	0.000844	CcSEcCtD
Bexarotene—Diarrhoea—Naltrexone—alcohol dependence	0.000342	0.000841	CcSEcCtD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—alcohol dependence	0.000341	0.00225	CbGpPWpGaD
Bexarotene—Loss of consciousness—Citalopram—alcohol dependence	0.000341	0.000839	CcSEcCtD
Bexarotene—Cough—Citalopram—alcohol dependence	0.000338	0.000833	CcSEcCtD
Bexarotene—Vomiting—Acamprosate—alcohol dependence	0.000336	0.000826	CcSEcCtD
Bexarotene—Hypertension—Citalopram—alcohol dependence	0.000335	0.000824	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—ADH1B—alcohol dependence	0.000335	0.00221	CbGpPWpGaD
Bexarotene—Rash—Acamprosate—alcohol dependence	0.000333	0.00082	CcSEcCtD
Bexarotene—Dermatitis—Acamprosate—alcohol dependence	0.000332	0.000819	CcSEcCtD
Bexarotene—Headache—Acamprosate—alcohol dependence	0.000331	0.000814	CcSEcCtD
Bexarotene—Dizziness—Naltrexone—alcohol dependence	0.00033	0.000813	CcSEcCtD
Bexarotene—Chest pain—Citalopram—alcohol dependence	0.00033	0.000813	CcSEcCtD
Bexarotene—Arthralgia—Citalopram—alcohol dependence	0.00033	0.000813	CcSEcCtD
Bexarotene—Myalgia—Citalopram—alcohol dependence	0.00033	0.000813	CcSEcCtD
Bexarotene—Anxiety—Citalopram—alcohol dependence	0.000329	0.00081	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000328	0.000807	CcSEcCtD
Bexarotene—Discomfort—Citalopram—alcohol dependence	0.000326	0.000803	CcSEcCtD
Bexarotene—Dry mouth—Citalopram—alcohol dependence	0.000323	0.000795	CcSEcCtD
Bexarotene—Confusional state—Citalopram—alcohol dependence	0.000319	0.000786	CcSEcCtD
Bexarotene—Vomiting—Naltrexone—alcohol dependence	0.000317	0.000782	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000317	0.0021	CbGpPWpGaD
Bexarotene—Oedema—Citalopram—alcohol dependence	0.000316	0.000779	CcSEcCtD
Bexarotene—Rash—Naltrexone—alcohol dependence	0.000315	0.000775	CcSEcCtD
Bexarotene—Dermatitis—Naltrexone—alcohol dependence	0.000315	0.000775	CcSEcCtD
Bexarotene—Infection—Citalopram—alcohol dependence	0.000314	0.000774	CcSEcCtD
Bexarotene—Nausea—Acamprosate—alcohol dependence	0.000313	0.000772	CcSEcCtD
Bexarotene—Headache—Naltrexone—alcohol dependence	0.000313	0.00077	CcSEcCtD
Bexarotene—Shock—Citalopram—alcohol dependence	0.000311	0.000767	CcSEcCtD
Bexarotene—Nervous system disorder—Citalopram—alcohol dependence	0.00031	0.000764	CcSEcCtD
Bexarotene—Thrombocytopenia—Citalopram—alcohol dependence	0.00031	0.000763	CcSEcCtD
Bexarotene—Tachycardia—Citalopram—alcohol dependence	0.000309	0.00076	CcSEcCtD
Bexarotene—Skin disorder—Citalopram—alcohol dependence	0.000307	0.000757	CcSEcCtD
Bexarotene—Hyperhidrosis—Citalopram—alcohol dependence	0.000306	0.000753	CcSEcCtD
Bexarotene—Anorexia—Citalopram—alcohol dependence	0.000302	0.000743	CcSEcCtD
Bexarotene—Nausea—Naltrexone—alcohol dependence	0.000297	0.00073	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000296	0.00196	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000293	0.00193	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000292	0.00193	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADH6—alcohol dependence	0.000292	0.00193	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000289	0.00191	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000288	0.00071	CcSEcCtD
Bexarotene—Insomnia—Citalopram—alcohol dependence	0.000286	0.000705	CcSEcCtD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000285	0.00188	CbGpPWpGaD
Bexarotene—Paraesthesia—Citalopram—alcohol dependence	0.000284	0.0007	CcSEcCtD
Bexarotene—Dyspnoea—Citalopram—alcohol dependence	0.000282	0.000695	CcSEcCtD
Bexarotene—Somnolence—Citalopram—alcohol dependence	0.000281	0.000693	CcSEcCtD
Bexarotene—Dyspepsia—Citalopram—alcohol dependence	0.000278	0.000686	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—MAOB—alcohol dependence	0.000277	0.00183	CbGpPWpGaD
Bexarotene—Decreased appetite—Citalopram—alcohol dependence	0.000275	0.000677	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000273	0.000673	CcSEcCtD
Bexarotene—Fatigue—Citalopram—alcohol dependence	0.000273	0.000672	CcSEcCtD
Bexarotene—Pain—Citalopram—alcohol dependence	0.000271	0.000666	CcSEcCtD
Bexarotene—Constipation—Citalopram—alcohol dependence	0.000271	0.000666	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—POMC—alcohol dependence	0.00027	0.00179	CbGpPWpGaD
Bexarotene—Feeling abnormal—Citalopram—alcohol dependence	0.000261	0.000642	CcSEcCtD
Bexarotene—Gastrointestinal pain—Citalopram—alcohol dependence	0.000259	0.000637	CcSEcCtD
Bexarotene—RXRA—PPARA activates gene expression—EP300—alcohol dependence	0.000256	0.00169	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000252	0.00166	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000251	0.00166	CbGpPWpGaD
Bexarotene—Abdominal pain—Citalopram—alcohol dependence	0.00025	0.000616	CcSEcCtD
Bexarotene—Body temperature increased—Citalopram—alcohol dependence	0.00025	0.000616	CcSEcCtD
Bexarotene—RXRA—Metabolism—ADH1A—alcohol dependence	0.000242	0.0016	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000241	0.00159	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	0.000236	0.00156	CbGpPWpGaD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000234	0.00155	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000234	0.00155	CbGpPWpGaD
Bexarotene—Hypersensitivity—Citalopram—alcohol dependence	0.000233	0.000574	CcSEcCtD
Bexarotene—Asthenia—Citalopram—alcohol dependence	0.000227	0.000559	CcSEcCtD
Bexarotene—Pruritus—Citalopram—alcohol dependence	0.000224	0.000551	CcSEcCtD
Bexarotene—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000221	0.00146	CbGpPWpGaD
Bexarotene—Diarrhoea—Citalopram—alcohol dependence	0.000216	0.000533	CcSEcCtD
Bexarotene—RXRA—Developmental Biology—GRIN2B—alcohol dependence	0.000215	0.00142	CbGpPWpGaD
Bexarotene—Dizziness—Citalopram—alcohol dependence	0.000209	0.000515	CcSEcCtD
Bexarotene—RXRA—Metabolism—ADH4—alcohol dependence	0.000206	0.00136	CbGpPWpGaD
Bexarotene—Vomiting—Citalopram—alcohol dependence	0.000201	0.000495	CcSEcCtD
Bexarotene—Rash—Citalopram—alcohol dependence	0.000199	0.000491	CcSEcCtD
Bexarotene—Dermatitis—Citalopram—alcohol dependence	0.000199	0.000491	CcSEcCtD
Bexarotene—Headache—Citalopram—alcohol dependence	0.000198	0.000488	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000192	0.00127	CbGpPWpGaD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.00019	0.00126	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	0.000188	0.00125	CbGpPWpGaD
Bexarotene—Nausea—Citalopram—alcohol dependence	0.000188	0.000463	CcSEcCtD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000186	0.00123	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000183	0.00121	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.00018	0.00119	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000178	0.00118	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADH7—alcohol dependence	0.000175	0.00115	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—GGT1—alcohol dependence	0.000173	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000173	0.00114	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT2—alcohol dependence	0.000168	0.00111	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.000165	0.00109	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000155	0.00103	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—MAOA—alcohol dependence	0.000155	0.00102	CbGpPWpGaD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000155	0.00102	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ADH1B—alcohol dependence	0.000153	0.00101	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000149	0.000982	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MAOB—alcohol dependence	0.000127	0.000839	CbGpPWpGaD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000125	0.000828	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000124	0.000821	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000123	0.00081	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000114	0.000754	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADH6—alcohol dependence	0.000109	0.00072	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—ALDH2—alcohol dependence	0.000108	0.000713	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000104	0.000686	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000102	0.000676	CbGpPWpGaD
Bexarotene—CYP2C9—Biological oxidations—POMC—alcohol dependence	0.000101	0.000667	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT2—alcohol dependence	9.18e-05	0.000607	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADH1A—alcohol dependence	9.02e-05	0.000596	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP2E1—alcohol dependence	8.63e-05	0.00057	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GGT1—alcohol dependence	7.93e-05	0.000524	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GOT1—alcohol dependence	7.93e-05	0.000524	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EP300—alcohol dependence	7.71e-05	0.00051	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADH4—alcohol dependence	7.67e-05	0.000507	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADH6—alcohol dependence	7.18e-05	0.000475	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—MAOA—alcohol dependence	7.1e-05	0.000469	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.89e-05	0.000455	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.66e-05	0.00044	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.64e-05	0.000439	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADH7—alcohol dependence	6.52e-05	0.000431	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT2—alcohol dependence	6.26e-05	0.000413	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.95e-05	0.000393	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ADH1B—alcohol dependence	5.72e-05	0.000378	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADH4—alcohol dependence	5.06e-05	0.000334	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MAOB—alcohol dependence	4.74e-05	0.000313	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—POMC—alcohol dependence	4.62e-05	0.000306	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADH7—alcohol dependence	4.3e-05	0.000284	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT2—alcohol dependence	4.13e-05	0.000273	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.03e-05	0.000266	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.88e-05	0.000256	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.77e-05	0.000249	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT2—alcohol dependence	3.43e-05	0.000226	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.22e-05	0.000213	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MAOB—alcohol dependence	3.13e-05	0.000207	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—EP300—alcohol dependence	3.07e-05	0.000203	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GOT1—alcohol dependence	2.96e-05	0.000195	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GGT1—alcohol dependence	2.96e-05	0.000195	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.66e-05	0.000176	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—MAOA—alcohol dependence	2.65e-05	0.000175	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.57e-05	0.00017	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT2—alcohol dependence	2.26e-05	0.000149	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.13e-05	0.00014	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GGT1—alcohol dependence	1.95e-05	0.000129	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GOT1—alcohol dependence	1.95e-05	0.000129	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—MAOA—alcohol dependence	1.75e-05	0.000116	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—POMC—alcohol dependence	1.73e-05	0.000114	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EP300—alcohol dependence	1.15e-05	7.57e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—POMC—alcohol dependence	1.14e-05	7.52e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EP300—alcohol dependence	7.55e-06	4.99e-05	CbGpPWpGaD
